EMA backs sev­en ther­a­pies, in­clud­ing Mer­ck­'s Ebo­la vac­cine

The first-ever Ebo­la vac­cine is on the precipice of ap­proval af­ter the Eu­ro­pean Med­i­cine’s Agency (EMA) backed the Mer­ck prod­uct in this week’s ros­ter of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.